Mayo Clinic

Mayo Clinic researchers identify new enzyme to fight Alzheimer's

Wednesday, September 19, 2012 12:58 PM

An enzyme that could represent a powerful new tool for combating Alzheimer's disease has been discovered by researchers at Mayo Clinic in Florida.

More... »

PCORI seeks input on draft methodology report

Wednesday, July 25, 2012 11:08 AM

The Patient-Centered Outcomes Research Institute (PCORI), an independent nonprofit organization authorized by Congress, has opened a public comment period for its draft Methodology Report,which proposes standards for the conduct of patient-centered outcomes research (PCOR).

More... »

ImmunAid completes Round 1 funding for immune cycle concept

Friday, April 13, 2012 01:51 PM

ImmunAid, a private Australian-based biotech, has successfully completed its first capital raising over $1 million from independent arm's-length investors in the U.S., Europe and Australia.

More... »

NinePoint Medical initiates trial of imaging system for esophagus

Tuesday, March 6, 2012 06:10 AM

NinePoint Medical, a developer of medical devices for in vivo pathology, has initiated a clinical trial to evaluate high-resolution optical imaging of Barrett’s esophagus using its proprietary Nvision VLE Imaging System, which received 510(k) clearance from the FDA earlier this year.

More... »

Complete Genomics to provide whole genome sequencing to Mayo Clinic

Friday, February 17, 2012 01:44 PM

Complete Genomics has been selected by Mayo Clinic's Center for Individualized Medicine to provide outsourced whole human genome sequencing.

More... »

EntreMed names two to board of directors

Tuesday, February 7, 2012 01:07 PM

EntreMed, a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, has appointed Wei-Wu He, Ph.D, executive chairman of its board of directors, and Tak W. Mak, Ph.D, as member of the board of directors.

More... »

Drug improves survival of colorectal cancer patients

Wednesday, January 18, 2012 12:02 PM

Phase II trial results show investigational drug regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, said Mayo Clinic oncologist Axel Grothey, the U.S. trial’s principal investigator.

More... »

Delcath names Gores to medical advisory board

Thursday, December 22, 2011 11:57 AM

More... »

Senesco initiates dosing in SNS01-T study

Thursday, November 3, 2011 10:12 AM

Senesco Technologies has initiated dosing in its phase Ib/IIa clinical study of SNS01-T at the Mayo Clinic in Rochester, MN. The study is an open-label, multiple-dose, dose-escalation study which will evaluate the safety and tolerability of SNS01-T when administered by intravenous infusion to relapsed or refractory multiple myeloma patients.

More... »

Taplmmune, Aeras ink research collaboration

Thursday, November 3, 2011 09:55 AM

TapImmune has signed a research collaboration with Aeras. The overall goal of this collaboration will be to evaluate the efficacy of TAP in concert with novel vaccine vectors encoding TB immunogens under development at Aeras with the aim of advancing suitable candidates to clinical development. Aeras will conduct all pre-clinical development studies at their laboratories in Rockville, MD.

More... »